Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats.
Journal
International journal of endocrinology
ISSN: 1687-8337
Titre abrégé: Int J Endocrinol
Pays: Egypt
ID NLM: 101516376
Informations de publication
Date de publication:
2019
2019
Historique:
received:
27
06
2019
accepted:
29
08
2019
entrez:
28
11
2019
pubmed:
28
11
2019
medline:
28
11
2019
Statut:
epublish
Résumé
Osteoporosis patients with chronic kidney disease (CKD) are becoming common in our superaging society. Renal dysfunction causes phosphorus accumulation in the circulating plasma and leads to the development of CKD-mineral bone disorder (MBD). We have previously reported that type III Pi transporter-overexpressing transgenic (Pit-1 TG) rats manifest phosphate (Pi)-dependent podocyte injury. In the present study, we explored the effect of risedronate on Pi-induced podocyte injury
Identifiants
pubmed: 31772574
doi: 10.1155/2019/4194853
pmc: PMC6854176
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4194853Informations de copyright
Copyright © 2019 Yohei Asada et al.
Déclaration de conflit d'intérêts
There are no conflicts of interest regarding the publication of this paper.
Références
Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6222s-6230s
pubmed: 17062705
Am J Kidney Dis. 2011 Nov;58(5):835-45
pubmed: 21715071
Bonekey Rep. 2014 Feb 05;3:497
pubmed: 24605214
Circ Res. 2000 Sep 29;87(7):E10-7
pubmed: 11009570
Endocr J. 2007 Feb;54(1):103-12
pubmed: 17135708
Mayo Clin Proc. 2008 Sep;83(9):1032-45
pubmed: 18775204
J Bone Miner Metab. 2010 Mar;28(2):139-48
pubmed: 19795094
Am J Pathol. 2002 Nov;161(5):1597-606
pubmed: 12414508
Biol Pharm Bull. 2017;40(1):25-33
pubmed: 28049945
J Bone Miner Metab. 2014 Jul;32(4):337-50
pubmed: 24818875
Bone. 2013 Nov;57(1):277-83
pubmed: 23988275
Dev Cell. 2006 May;10(5):549-61
pubmed: 16678772
Kidney Res Clin Pract. 2012 Jun;31(2):87-93
pubmed: 26889414
FASEB J. 2007 May;21(7):1367-75
pubmed: 17307840
Am J Kidney Dis. 2008 Oct;52(4):661-71
pubmed: 18805347
Kidney Int. 2013 Sep;84(3):545-54
pubmed: 23615507
Kidney Int. 2012 Jun;81(11):1075-85
pubmed: 22278020
Nephrol Dial Transplant. 2007 Oct;22(10):2909-16
pubmed: 17517792
Intern Med. 2017 Dec 15;56(24):3271-3276
pubmed: 29021477
J Clin Invest. 1997 Jan 15;99(2):342-8
pubmed: 9006003
J Am Soc Nephrol. 1996 Dec;7(12):2518-26
pubmed: 8989729
Physiol Rev. 2008 Apr;88(2):451-87
pubmed: 18391170
Am J Kidney Dis. 2017 Dec;70(6):737-751
pubmed: 28941764
J Clin Invest. 1999 Dec;104(11):1559-66
pubmed: 10587519
Pediatr Nephrol. 2004 Feb;19(2):130-7
pubmed: 14673634
Curr Osteoporos Rep. 2015 Dec;13(6):372-80
pubmed: 26409849
Kidney Int. 2006 Nov;70(9):1577-83
pubmed: 16955099
Arthritis Rheumatol. 2017 Aug;69(8):1521-1537
pubmed: 28585373
Clin Exp Nephrol. 2003 Dec;7(4):255-9
pubmed: 14712353
J Am Soc Nephrol. 2011 Sep;22(9):1621-30
pubmed: 21804090
Am Fam Physician. 2016 Mar 15;93(6):479-85
pubmed: 26977832
J Intern Med. 2015 Jul;278(1):19-28
pubmed: 25758353
Endocrinol Metab (Seoul). 2017 Jun;32(2):180-189
pubmed: 28555464
Nephrol Dial Transplant. 2003 Oct;18(10):2014-23
pubmed: 13679475
Brain Res. 2016 Apr 15;1637:128-136
pubmed: 26923164
Basic Clin Pharmacol Toxicol. 2005 Dec;97(6):374-81
pubmed: 16364053
Am J Physiol Renal Physiol. 2011 Apr;300(4):F848-56
pubmed: 21307129
Ann N Y Acad Sci. 1996 Dec 27;804:142-64
pubmed: 8993542
Nat Rev Nephrol. 2013 Aug;9(8):470-7
pubmed: 23774818
Genesis. 2009 Dec;47(12):858-63
pubmed: 19882669
Adv Enzyme Regul. 2000;40:285-302
pubmed: 10828356
Kidney Int. 2006 Jun;69(12):2131-47
pubmed: 16688120